Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_assertion type Assertion NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_head.
- NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_assertion description "[Moreover, combined therapeutic inhibition of EGFR and c-Kit may abrogate this acquired mechanism of drug resistance due to an enhanced apoptotic effect in gefitinib-resistant xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_provenance.
- NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_assertion evidence source_evidence_literature NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_provenance.
- NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_assertion SIO_000772 25510664 NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_provenance.
- NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_assertion wasDerivedFrom befree-2016 NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_provenance.
- NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_assertion wasGeneratedBy ECO_0000203 NP1248236.RAsXKz9QmoR6qJLwUyxeI01zr1aZlCGCowSzFqhJLeizA130_provenance.